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Abstract.  Laminin derived from the Engelbreth- 
Holm-Swarm (EHS) tumor and a  lamininlike molecule 
synthesized by RN22  Schwannoma cells both stimulate 
rapid neurite outgrowth, consistent with a  common 
neurite-promoting site.  However, antilaminin antisera 
can only inhibit the activity of the EHS laminin. The 
blocking antibodies in such sera are directed against 
the terminal heparin-binding domain of the laminin 
long arm (Edgar, D.,  R.  Timpl, and H.  Thoenen. 
1984.  EMBO [Eur. Mol.  Biol.  Organ.] J.  3:1463-1468). 
These epitopes are demonstrated by immunoblotting to 
be part of the A  chain and to be absent in RN22  lami- 
nin, showing (through metabolic labeling) that the 
cells synthesized little if any 440-kD  A  chain.  This in- 
dicates that the antibody inhibition was probably due 
to steric hindrance, a common neurite-promoting site, 
apparently not being antigenic in native molecules. 
Antibodies raised against a  25-kD proteolytic fragment 
derived from the long arm of laminin were then used 
as probes to identify other potential neurite-promoting 
structures.  Although these antibodies do not cross- 
react with native laminin, they recognized the B 
chains of denatured EHS and RN22  molecules on im- 
munoblots. The antibodies also bound to the large pro- 
teolytic fragment, derived from the long arm of lami- 
nin that contains the neurite-promoting site, thus 
inhibiting its activity. Taken together, these results 
point to the localization of normally nonantigenic, 
defined, B chain sequences within or close to the 
neurite-promoting site of laminin. 
N 
'EURONS can be stimulated to extend neurites rapidly 
when cultured on substrates consisting either of spe- 
cific cell types (notably glia [19, 29]), or alternatively 
if the substrate contains molecules secreted or "shedded" by 
many types of cells (2, 8). Although the cell surface mole- 
cules responsible for stimulating neurite outgrowth are cur- 
rently only starting to be identified (see references 4, 5, 35), 
the well-characterized basement membrane protein laminin 
(26) has been shown to evoke many effects of extracellular 
matrices on neural cells: when used as a tissue culture sub- 
strate, laminin stimulates rapid neurite outgrowth (3), poten- 
tiates  the  survival-promoting activities  of soluble  neuro- 
trophic factors (16), and can both induce an activation and 
increase the amount of the enzyme tyrosine hydroxylase in 
adrenal chromaffin cells (1). Laminin has also been shown 
to stimulate the division of Schwann cells (27). 
Antibody inhibition studies have been used to analyze the 
molecular structures mediating these effects of laminin; the 
ability of domain-specific antibodies to block the effect of 
laminin on neural cells indicates that a site at or near the end 
of the long arm of laminin (see Fig. 1) is responsible for the 
stimulation of neurite outgrowth (16, 17), potentiation of neu- 
ronal survival (16), and induction of tyrosine hydroxylase (1). 
The blocking antibodies detected in the original study were 
all directed against a 50-kD heparin-binding fragment (E3) 
derived from the terminal globular domain from the long 
arm of mouse Engelbreth-Holm-Swarm (EHS) ~  tumor lam- 
inin (16). Direct evidence for the involvement of this do- 
main could not be provided, however, because the heparin- 
binding fragment itself had no stimulatory effect on neurons. 
Indeed, the smallest proteolytic fragment of iaminin (E8; 
Mr "~280 kD) able to promote neurite outgrowth consisted 
not only of the whole terminal globular domain, but also 
contained a 30-nm rodlike segment of the long arm (16; see 
Fig.  1).  More recently, it has been shown that monoclonal 
antibodies directed against epitopes on or near to the termi- 
nal globular domain from the long arm of human placental 
laminin can also inhibit neurite outgrowth to some extent 
(17). Significantly, the degree of antibody inhibition was in- 
creased by the use of secondary antibodies in a sandwich, 
consistent with inhibition caused by  steric  hindrance,  al- 
though other possibilities(e.g., changes in antibody affinity) 
might also account for ~/lch findings (17). 
In addition to purified EHS laminin, a considerable num- 
ber of other neurite-promoting factors have been described, 
the activity of which appears to be due to laminin that is often 
complexed  noncovalently with proteoglycan and  with the 
protein entactin/nidogen (12, 13, 24,  25).  Antisera against 
1.  Abbreviation used in this paper:  EHS,  Engelbreth-Holm-Swarm. 
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images  (inserts) and  sche- 
matic drawings of EHS lami- 
nin  (a)  and  RN22  cell  lami- 
nin (b). For rotary shadowing, 
EHS laminin was prepared as 
described previously (39), and 
RN22 laminin was isolated es- 
sentially as described (12; Ed- 
gar, D., and M. Paulsson, un- 
published  observations).  The 
location  of  the  polypeptide 
chains in the illustration of EHS 
laminln (a) is based on recently 
proposed models (26, 41). The 
origins within the native lami- 
nin molecule of the proteolyt- 
ic fragments used in this study 
are indicated by brackets. Con- 
tributions  of  the  three  lam- 
inin polypeptide chains to each 
fragment are shown in the il- 
lustration,  although it should 
be noted that the 25-kD fragment consists only of two disulfide-bonded polypeptides derived from the B chains (33),  and fragment E8 
is derived exclusively from the laminin A chain (41). The molecular masses of the fragments have previously been determined to be 50 
kD for E3 (30); 280 kD for E8 (33); 700 kD for El-4 (30,  38);  and 25 kD for 25K (33).  Fragment E3 comprises part of the terminal 
globular domain of the long arm, and has been shown both to bind heparin (30) and to provide the epitopes necessary for antibody inhibition 
of neurite outgrowth on native laminin (16). The locations of the polypeptide chains of RN22 laminin (b) are tentative and their identities 
open to speculation; the drawing is a hypothetical working model based on the rotary shadowing image (12). Drawings are not to scale. 
Bar, 50 nm. 
EHS laminin cannot block the neurite-promoting activity of 
such  factors,  although  some antibody recognition evidently 
occurs as the antisera  can immunoprecipitate  the activities 
(12-14,  24,  25).  To explain these findings,  it has been pro- 
posed that the proteoglycan of the neurite-promoting  com- 
plex could mask those epitopes necessary for antibody inhi- 
bition  of  neurite  outgrowth  (24).  It  has,  however,  been 
demonstrated that the complex of proteoglycan and laminin 
can  create  an  epitope  that  is  absent  on  either  component 
alone,  and  that  will  bind  antibodies  to  block  neurite  out- 
growth on  the complex (7). 
One particularly  well-studied  neurite-promoting  factor is 
that produced  by RN22  rat Schwannoma  cells,  the activity 
of which is also not inhibited by antisera against laminin (12, 
13).  This factor has been shown to consist of laminin mole- 
cules that lack the 440-kD A chain and, according to current 
models (39), might consequently be expected also to lack the 
heparin-binding fragment, E3, previously implicated in neu- 
rite outgrowth  (16).  A  comparison between the laminins  of 
the EHS tumor and RN22 cells, with respect to their struc- 
ture and interactions with antibodies, therefore affords an ex- 
cellent opportunity to define the neurite-promoting site more 
precisely:  it  is  to  be  expected  that  the  laminin  molecular 
structures involved in neurite stimulation will be common to 
both molecules.  Taken together, the results of this compari- 
son point for the first time to the involvement of laminin long 
arm B  chain  sequences  in  its neurite-promoting  site. 
Materials and Methods 
Preparation of  Laminin, Proteolytic Fragments, 
and Antibodies 
Laminin was purified from the mouse EHS tumor as previously described 
(39). The laminin-nidogen complex was isolated by a more recent proce- 
dure from which the E8 fragment could be prepared by mild proteolytic 
digestion with elastase (32).  The El-4 and 25-kD  proteolytic fragments 
were prepared as described (30, 33, 38) and laminin and its fragments used 
for the immunization of rabbits by standard procedures (37).  Antibodies 
were then purified from the antisera by affinity chromatography (37). Anti- 
body cross-reactivities and antigen-binding capacities (see reference 28) 
were determined by standard radioimmunobinding assays using solutions of 
laminin and its fragments (37). 
Neurite Outgrowth Assay 
Tissue culture multiwell plates (24-well  cluster; Costar, Cambridge, MA) 
were first coated with poly-oL-ornithine (Sigma Chemical Co., St. Louis, 
MO) and then incubated overnight at 4~  with samples to be tested for 
neurite-promoting activity (15, 16). The amount of laminin and fragment E8 
adsorbed  to  the  culture  substrate  was  determined  by  including  small 
amounts  of ligand  that  had  been labeled with  ~25I (Amersham Buchler 
GmBH, Braunschweig, FRG) by the cbloramine T method (37). At the low 
ligand concentrations necessary for maximal neurite outgrowth it was found 
that some 35-45% of laminin or fragment E8 bound to the substrate. The 
neurons used were dissociated from the paravertebral sympathetic ganglia 
of  12-d-old  chick embryos,  and  separated from nonneuronal cells by  a 
preplating technique (15, 16). The culture medium was F14 (Gibco, Karls- 
ruhe, FRG) containing 50 gg/m| streptomycin sulfate and 50 U/ml penicillin 
sulfate (Sigma Chemical Co.), together with 10% (vol/vol) heat-inactivated 
horse serum (Gibeo) and 20 ng/ml 2.5S nerve growth factor,  prepared in 
our laboratory as described (36).  Neurons (2,000/well) were cultivated in 
400  gl  of medium, and essentially all  of them attached to the substrate 
within 30 min. Neurite outgrowth was evaluated  by phase-contrast micros- 
copy after 2 h of culture, and quantified by counting the percentage of neu- 
rons with neurites in randomly chosen fields of view.  Variation  between 
different fields of view in the same dish and between duplicate dishes was 
always <10%. Neurites were defined as processes of length equivalent to at 
least five cell diameters ("o50  gin), and under the conditions of the assay 
no neurite development was apparent unless laminin or an equivalent sub- 
strate was used (see reference 16). 
Preparation of Conditioned Media 
and Metabolic Labeling 
The mouse PYS-2 teratocarcinoma cell line (provided by J.  M.  Lehman, 
University of Colorado) and the rat RN22 Schwannoma cell line (provided 
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antibiotics described for the neurite assay,  and  supplemented with  10% 
(vol/vol) FCS (Gibco). Preliminary experiments showed that the maximal 
neurite-promoting activity of RN22-conditioned medium was found after 
3 d culture of confluent cells, and it was this medium used in the experi- 
ments shown. 
For long-term metabolic labeling, confluent PYS-2 and RN22 cells in 
35-mm tissue culture dishes were incubated overnight with  1.5 ml  DME 
supplemented with  1%  (vol/vol)  FCS  and  100  p_Ci/ml [35S]methionine 
(800 Ci/mmol; New England Nuclear Chemicals, Dreieich, FRG). After 
collection the media were centrifuged to remove cell debris, supplemented 
with 2 mM phenylmethylsulfonyl fluoride (PMSF; Sigma Chemical Co,, 
and stored at  -70~  until required. 
For short-term pulse-chase experiments, confluent PYS-2  and  RN22 
cells in multiwell culture plates were incubated for 1 h in 0.5 ml methionine- 
free DME containing  10%  (vol/vol) dialyzed FCS.  The cells were then 
pulsed for 10 min with the same medium containing 100 ttCi/ml [35S]me- 
thionine, after which time the labeled medium was replaced by  normal 
DME plus 10% (vol/vol) FCS. The cells were extracted at the chase times 
shown using 50 mM Tris-HCl, pH 7.8, containing 150 mM NaCI, 1% Triton 
X-100, 2 mM N-ethylmaleimide, 2 mM EDTA,  and 2 mM PMSE The ex- 
tracts (500 ~l/culture well) were centrifuged to remove debris and stored 
at  -70~  until  required. 
Immunoprecipitation 
Aliquots of culture medium (20-100 pl) were added to 800 ~tl of immunopre- 
cipitation buffer (50 mM Tris-HCl, pH 7.8, 150 mM NaCI, 1% Triton X-100, 
2 mM N-ethylmaleimide, 2 mM EDTA,  2 mM PMSF) containing 100 I.tl 
of Staphylococcus  aureus  suspension (10%  in  the  immunoprecipitation 
buffer; pansorbin; Calbiochem, Frankfurt, FRG). After preadsorption for 
1 h at room temperature, the Pansorbin was removed by centrifugation and 
10 I.tg of antibodies added to the supernatant. The mixture was shaken for 
45 rain at room temperature, 50 I.tl of the Pansorbin suspension was added, 
and adsorptions were carried out tor a further 45 min. The Pansorbin pellets 
were then washed twice with immunoprecipitation buffer,  and twice with 
50 mM Tris-HCI, pH 7.8, containing 1 M NaCI, I% NP-40, and the protease 
inhibitors. Pellets were then boiled for 5 min in 60 I.tl of Laemmli sample 
buffer (23), with or without 2-mercaptoethanol, and subjected to SDS-PAGE 
on 3-6% exponential gradient gels (23).  The gels were calibrated with a 
standard of the laminin-nidogen complex  (32)  and  3~S-labeled proteins 
were detected by fluorography at -70~  using Fuji x-ray film, after impreg- 
nating the gels with  1 M  sodium salicylate. 
Immunoblots 
Aliquots of conditioned medium  (250-1,000  ~tl) were treated with  12% 
(wt/vol) polyethylene glycol 6,000 (Serva, Heidelberg, FRG) to precipitate 
high molecular weight components. The precipitates were rinsed with 70 % 
ethanol and dissolved in Laemmli sample buffer for SDS-PAGE on 3-6% 
gels (see above).  After electrophoresis, proteins were electrotransferred 
onto nitrocellulose (40), and the blots calibrated by staining transferred stan- 
dards reversibly with 0.1% Ponceau S 5% TCA (Sigma Chemical Co.). Af- 
ter destaining with water, the nitrocellulose was blocked with 50 mM Tris- 
HCI,  pH  7.8, plus  150 mM  NaCI  (TBS)  containing 2.5%  (wt/vol) BSA 
(Sigma Chemical Co.), 0.2% Tween 20 (Sigma Chemical Co.), and 0.02% 
(wt/vol) sodium azide. Blocking was for 30 min at 40~  followed by  1 h 
at room temperature. Blots were then incubated with the antibodies shown 
(10 I.tg/ml) for 90 rain, and then washed extensively in TBS.  Detection of 
the  bound antibodies was  by  -~S-labeled  protein A  (1  I.tCi/ml,  700  Ci/ 
mmol; Amersham Buchler GmBH, Braunschweig, FRG) dissolved in the 
above blocking buffer. After 90 rain at room temperature the nitrocellulose 
was extensively washed in TBS  and blotted dry on filter paper (3  MM; 
Whatman Inc., Clifton, NJ). Exposure of Fuji x-ray film to the blot for auto- 
radiography was generally  1-2 d. 
Results 
Stimulation of  Neurite Outgrowth 
Sympathetic neurons rapidly extended neurites when grown 
on substrates  of laminin,  on the E8  long arm  fragment of 
laminin (Fig.  1), or alternatively on substrate-attached mole- 
cules  from the conditioned medium of RN22 Schwannoma 
cells (Fig. 2). The assay method used here involved precoat- 
ing the tissue culture plastic with poly-DL-ornithine, before 
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Figure 2. Dose-response curves for the stimulation  of neurite out- 
growth by different  laminin  substrates.  Poly-oL-ornithine-coated 
tissue culture wells were incubated overnight with various amounts 
of EHS tumor laminin  (zx), fragment  E8 (o), and RN22 Schwan- 
noma-conditioned medium (e). The amounts of laminin and E8 ad- 
hering to the wells was determined by including  trace amounts of 
~25I-labeled protein.  2,000 sympathetic  neurons were then cultured 
in the wells for 2 h and the percentage  of neurons displaying  neu- 
rites of length greater than 5 cell diam (>60 I,  tm) was determined. 
The values shown are the means of duplicate cultures (variation be- 
tween individual values <5%) and are typical of at least five inde- 
pendent  experiments. 
coating  with  laminin  or  other  neurite-promoting  factors. 
Thus the same numbers of neurons attached to the culture 
substrates irrespective of the presence or absence of laminin 
(see reference  16), and so the percentages of those neurons 
with neurites after 2 h culture are directly comparable from 
substrate to substrate.  It should be noted that the maximal 
levels of neurite outgrowth were broadly similar for the three 
substrates, the apparently higher potency of E8 (with respect 
to that of laminin) reflecting its lower molecular weight; half 
maximal stimulation of neurite outgrowth occurred when the 
density of laminin or E8 substrate was ,x,10 fmol/cm  2. Esti- 
mates  of the speed of neurite  outgrowth generated  similar 
dose-response curves, with maximal rates of ~1  I.tm/min.  A 
substrate coating density of 100 ng per multiwell was there- 
fore chosen for subsequent antibody inhibition studies. Simi- 
larly,  100 I.tl of RN22-conditioned medium was used to coat 
the wells for the inhibition studies, this amount giving maxi- 
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Figure 3. Antibody inhibition of neurite outgrowth on laminin (..4) 
and on fragment E8 (B). Conditions of the assay are those de- 
scribed in Fig. 2,  100 ng of laminin and fragment E8 being bound 
to the wells. The antigen-binding capacities (ABC) of antibodies in- 
cluded throughout the culture period are given: (o) anti-E3; (zx) 
anti-El-4;  (A) anti-25-kD. Means of duplicate cultures are shown, 
and are typical of three independent experiments. 
mal neurite outgrowth, equivalent to that seen with  100 ng 
bound laminin or E8 (Fig. 2). 
Antibody Inhibition of Neurite Outgrowth 
As previously described (16),  antibodies against fragment 
E3, derived from the terminal globular domain of the long 
arm oflaminin (see Fig. 1), inhibited neurite outgrowth both 
on laminin (Fig. 3 A) and E8 (Fig. 3 B). In contrast, equiva- 
lent amounts of antibodies directed against  the  short arm 
fragment El-4 failed to inhibit neurite outgrowth on either 
substrate (Fig.  3).  This pattern of antibody inhibition was 
also seen for PYS-2 cell laminin (data not shown, see also 
reference 24).  Significantly,  while  antibodies  against  the 
25-kD long arm fragment (see Fig.  1) displayed only slight 
(maximally 20 %) inhibition of neurite outgrowth on laminin 
(Fig. 3 A) these antibodies were able to block neurite out- 
growth on E8 totally, being as effective as the anti-E3 anti- 
bodies (Fig. 3 B). None of these antibodies-or antibodies 
against whole laminin-inhibited neurite outgrowth on sub- 
strates  of RN22  conditioned  media  molecules  (data  not 
shown; see also references 12,  13, 24). 
Table L Immunoprecipitation of  Neurite-promoting 
Activities from Solution by Antibodies to Laminin 
and Its Fragments 
Percentage of neurite-promoting  activity 
remaining after immunoprecipitation of 
Antibody  EHS  Fragment  RN22 
against  laminin  E8  medium 
Control  86  75  81 
EHS laminin  2  5  5 
E 1-4  6  78  6 
E3  5  2  76 
25-kD  fragment  68  12  73 
1-ml aliquots of EHS laminin and fragment E8 (250 ng/ml in DME  +  10% 
FCS) and RN22-conditioned medium (250 ~1 diluted in  I ml DME  +  10% 
FCS) were mixed with the antibodies shown (antigen-binding capacities  1.25 
1.tg) for  I h at room temperature,  and for 1 h further after addition of 100 rtl 
Pansorbin (10% wt/vol  suspended in DME  +  10%  FCS).  The supernatants 
were used to coat polyornithine culture  substrates.  The results given are the 
means of duplicates (determined after 2 h culture),  that differed by <5%, and 
are typical of three independent experiments.  Control precipitation  was with 
nonimmune IgG. 
Antibody Recognition of Neurite-promoting Molecules 
As previously reported (12), antilaminin antibodies precipi- 
tated the neurite-promoting activities of laminin  solutions 
and  RN22-conditioned media  (Table I),  consistent with  a 
molecule antigenically related to laminin being responsible 
for the latter activity.  Similarly,  antibodies to the laminin 
fragment El-4 recognized both laminin and the RN22 mole- 
cules, indicating the presence of short-arm epitopes on the 
RN22 neurite-promoting molecule. The latter antibodies did 
not, of course, recognize the long-arm fragment E8, so that 
its  neurite-promoting activity was  left in solution. Signifi- 
cantly however, while recognizing both laminin and  frag- 
ment E8, the blocking antibodies against fragment E3 failed 
to precipitate the  neurite-promoting activity of the  RN22 
cells (Table I). Antibodies to the 25-kD fragment were found 
to be able to precipitate only E8 activity and not that of the 
RN22 cells or laminin. The last result is consistent with the 
previously noted low cross-reactivity between these antibod- 
ies and lamin (33). Immunoprecipitation of PYS-2 cell lami- 
nin gave essentially the same results as those for EHS lami- 
nin solutions in that anti-fragment E3 antibodies precipitated 
>80%  of the activity of PYS-2-conditioned medium. 
Immunoblotting experiments were then performed to de- 
termine the  reason for the  specific lack of recognition of 
RN22 neurite-promoting activity by anti-fragment E3 block- 
ing  antibodies.  While  antilaminin  antibodies  recognized 
both the A (440 kD) and B (220 kD) chains of EHS and PYS 
laminin, the same antibodies only detected two well resolved 
polypeptides of ,~220 kD on blots of RN22-conditioned me- 
dia molecules (Fig.  4  b).  The blocking antibodies against 
fragment E3  recognized only the A  chain of mouse  lam- 
inin (Fig. 4 c), consistent with the recent assignation of the 
heparin-binding domain of laminin to the A chain (see refer- 
ences 6, 26, 41). Significantly, anti-fragment E3 antibodies 
failed to cross-react on blots of RN22 molecules, indicating 
the absence (rather than masking) of E3 epitopes (Fig. 4 c). 
The anti-fragment 25-kD antibodies cross-reacted with the 
B chains of mouse laminin and with the 220-kD doublet of 
RN22 cell laminin on blots (Fig. 4 d). As previous work has 
shown fragment 25 kD to comprise the carboxyl-terminal seg- 
ments of the two B chains of laminin (33), then the 220-kD 
doublet of RN22  cell  laminin  can also  be  regarded  as  B 
chains. 
Metabolic Labeling Studies 
To compare the structures of RN22 and PYS-2 cell laminins 
in  more detail,  the cells  were metabolically labeled with 
[-~%]methionine, and the proteins released into their culture 
media analyzed by immunoprecipitation. As previously re- 
ported (12), antilaminin antibodies precipitated a relatively 
broad band of 35S-protein from the RN22  medium (Fig.  5 
a).  On  SDS-PAGE the  mobility  of the  slowest  migrating 
components of this band corresponded to that of PYS-2 lami- 
nin, whereas the bulk of the labeling migrated significantly 
faster (Fig.  5 a).  In addition,  a noncovalently bound band 
was  seen with a mobility equivalent to  150 kD.  This band 
was previously identified as nidogen (13). On reduction, the 
RN22 laminin was seen to comprise two well-defined chains 
of ",,220 kD that comigrated with the B chains of PYS lami- 
nin,  together with the  150-kD  band.  As previously noted, 
however (24), a small amount of labeled material could also 
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mouse  PYS-2  cell  laminin 
(M) and rat RN22 cell laminin 
(R). Proteins  from the culture 
media of these cells were sub- 
jected  to  SDS-PAGE  under 
nonreducing (a) and reducing 
(b-d)  conditions.  Antibodies 
used for immunostaining  were 
(a and b) antilaminin,  (c) anti- 
E3, (d) anti-25-kD. Detection 
of bound antibodies  was with 
'sS-labeled  protein  A,  fol- 
lowed by autoradiography. The 
laminin-nidogen  complex (32) 
was  included  as  molecular 
mass  standard  in  a  separate 
lane,  and  detected  after elec- 
trotransfer by staining the blots 
with  Ponceau  S.  L,  laminin 
(800 kD); N, nidogen/entactin 
(150 kD); A, laminin  A chain 
(440 kD); B, laminin B chains 
(220  kD). 
be seen migrating as a doublet slightly faster than the 440-kD 
laminin A chain (Fig. 5 b). The amounts of this doublet var- 
ied from experiment to experiment,  always being very small 
relative to the B chains, and often being undetectable-which 
perhaps might explain why its existence was not noted in sev- 
eral  previous studies  (12,  31). 
Figure 5. Immunoprecipitation of 135S]methionine-labeled proteins 
from mouse PYS-2 cell (M) and rat RN22 cell (R) conditioned me- 
dia.  Proteins were precipitated  with antilaminin  antibodies and Pan- 
sorbin,  and  subjected  to SDS-PAGE  under  nonreducing (a)  and 
reducing  (b) conditions.  Arrows show the origin of the separating 
gel and the buffer front,  and arrowheads  show the positions  of mo- 
lecular mass standards:  L laminin  (800 kD); N, nidogen  (150 kD); 
A, laminin A chain (440 kD): B, laminin B chains (220 kD).  Stan- 
dards  were  detected  by  staining  the  gel  with  Coomassie  Blue. 
35S-labeled proteins  were detected  by fluorography. 
To determine the reasons for the substoichiometric  label- 
ing  of this  doublet  and  for  the  broad  banding  of the  un- 
reduced RN22 cell laminin, the unreduced band was excised 
in three parts from the nonreducing gel and again subjected 
to SDS-PAGE, this time under reducing conditions. The re- 
suits  (Fig.  6)  indicate  that the broad banding of unreduced 
RN22 cell laminin is due to heterogeneity: only that part of 
the band comigrating relatively slowly with  PYS-2 laminin 
contains the high molecular weight doublet. The faster mov- 
ing components, corresponding to the bulk of the unreduced 
RN22  cell  laminin,  only  contained  the  B  chains  and  did 
not have any detectable  high molecular weight doublet:  in- 
deed  on  reduction,  the  fastest-migrating  portion  displayed 
the B chains together with an even smaller  labeled  band of 
'M80 kD. 
To exclude that the heterogeneity of RN22 cell laminin was 
due to degradation of any 440-kD A chain initially produced 
by these  cells,  preliminary  experiments  were performed  to 
show  that  no  selective  degradation  of ~25I-labeled EHS  tu- 
mor laminin chains could be detected when exposed to RN22 
cells  (data  not shown).  To exclude both external  and  intra- 
cellular degradation  of laminin components, a  pulse-chase 
experiment was performed,  labeling the laminin  with a  10- 
min pulse of [35S]methionine.  While equivalent  labeling  of 
both A and B chains of PYS-2 intracellular laminin was seen 
throughout the chase period (Fig. 7 b), little if any detectable 
A  chain could be detected  in the RN22 cells,  even immedi- 
ately after the pulse (Fig. 7 a). A similar labeling pattern was 
seen  in RN22 cells  that  had  been  continuously exposed to 
10  -4 M  leupeptin (Sigma Chemical Co.) for 18 h before and 
during  the pulse  to inhibit  lysosomal degradation  (data  not 
shown: see reference 20).  The lack of detectable 440-kD A 
chain from the RN22 cells is therefore most probably due to 
a  lack of synthesis,  rather  than  specific degradation. 
Discussion 
The results presented here show that RN22 Schwannoma cell 
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SDS-PAGE of (a) PYS-2 cell 
and  (b)  RN22 cell  immuno- 
precipitates.  35S-labeled im- 
munoprecipitates from condi- 
tioned media (see Fig. 4) were 
first subjected to electropho- 
resis under nonreducing con- 
ditions (-). Pieces of gel corre- 
sponding to L and A (a) and 1, 
2, and 3 (b) were excised and 
their proteins then  subjected 
to SDS-PAGE  under reducing 
conditions  (+).  Arrowheads 
show the positions of molecu- 
lar mass standards: L, laminin 
(800  kD),  N,  nidogen (150 
kD); A, laminin A chain (440 
kD); B, laminin B chains (220 
kD). 35S-labeled  proteins were 
detected by fluorography. 
laminin  is  not recognized by specifically those antibodies 
that can inhibit the neurite-promoting activity of EHS lami- 
nin.  This is due to the lack of the 440-kD A  chain in the 
majority of the RN22 laminin molecules, part of this chain 
constituting the heparin-binding  fragment which  contains 
the blocking epitopes. These observations indicate that this 
fragment is most likely not the actual neurite-promoting site 
of laminin, the most parsimonious hypothesis being that an- 
other (nonantigenic) site in the vicinity of the heparin-bind- 
ing fragment, and common to EHS and RN22 laminins,  is 
responsible  for  both  their  activities.  A  good  candidate 
fulfilling these criteria appears to be the sequence of the B 
chains of laminin, corresponding to the defined proteolytic 
25-kD  fragment.  This  fragment originates  from a  region 
close to the carboxyl terminus of the B chains, which is lo- 
cated near the heparin-binding domain of EHS laminin, and 
Figure 7.  Pulse-chase  metabolic labeling of laminin in (a) RN22 
and (b) PYS-2 cells. The cells were pulsed with [35S]methionine 
for 10 min followed  by a chase of unlabeled methionine for the times 
shown in minutes (min). The cells were extracted with detergent and 
the laminin in the extracts subjected  to immunoprecipitation  followed 
by SDS-PAGE under  reducing conditions and fluorography (see 
Fig. 5). Lane M shows the position of the laminin A (440 kD) and 
B (220 kD) chain molecular mass markers obtained from the cul- 
ture medium of PYS-2 cells labeled for 18 h with [35S]methionine. 
is  not antigenic within the native molecule (see reference 
33). However, on partial proteolysis of laminin to produce 
the long arm fragment containing its neurite-promoting site, 
E8, these epitopes become exposed so that they can nov,' bind 
antibodies. The resulting inhibition of  neurite outgrowth pro- 
vides direct evidence for the involvement of the B chains at 
or near to the neurite-promoting site of laminin from the 
EHS tumor, and also, by implication, of RN22 cell laminin 
and other neurite-promoting factors. 
Comparison of  EHS and RN22 Laminins 
The purpose of this comparison is not to present a compre- 
hensive structural analysis of the two laminin molecules (the 
complete molecular structure of EHS tumor laminin has still 
not been established; see references 26, 41); the point is to 
define molecular structures that are either unique to one vari- 
ant of laminin,  or alternatively that are shared by the two 
molecules, and which could therefore account for a common 
neurite-promoting site.  A  further aim of this analysis was 
to try to provide a  precise explanation in molecular terms 
for the lacking antibody inhibition of neurite outgrowth on 
RN22 cell laminin. 
Initial immunoprecipitation and  immunoblotting experi- 
ments showed that antibodies directed against the heparin- 
binding fragment of EHS laminin failed to recognize RN22 
cell iaminin.  Although this could be due to species differ- 
ences, we think it unlikely because it has been shown previ- 
ously that  mouse and  rat  laminins  are  antigenically very 
similar (18). Furthermore, the immunoblots presented here 
and elsewhere (6) indicated that the heparin-binding frag- 
ment of laminin is found on the A chain so that it seems the 
lack of the epitopes is a direct consequence of the absence 
of the 440-kD A chain. 
The presence of B chains without the 440-kD A chain has 
previously been reported for laminin from a variety of tissues 
and species,  including mouse (9,  11-13, 22,  24).  We show 
here by metabolic labeling that a  minor proportion of the 
laminin molecules synthesized by RN22 Schwannoma cells 
(estimated to be <20% from the data presented in Fig. 6) does 
indeed contain relatively high molecular mass components 
that migrate as a doublet, somewhat faster than the A chain 
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EHS tumor laminin (see also references 24, 34). The major- 
ity of the laminin molecules from the RN22 cells, however, 
consists of covalent oligomers of bands that, when reduced, 
migrate as 220-kD B chains with no detectable polypeptide 
migrating in the vicinity of the A chain. A third (minor) sub- 
population of molecules was found to also contain a compo- 
nent migrating somewhat faster than the B chains (Mr '~180 
kD).  The relationship of this polypeptide to the others re- 
mains unknown; it was not possible to obtain any evidence 
that it is a breakdown product of one of the larger chains, the 
occasional appearance of the  180-kD  band  not being cor- 
related with the decrease in the amount of any of the other 
bands. 
Since the mobility of RN22 cell laminin is only marginally 
faster than that of those molecules containing both A and B 
chains  (see  also  reference  12), then  RN22  laminin  most 
probably comprises more than just two B-chains held to- 
gether by disulfide bonds. This is indicated by rotary shadow- 
ing (Fig. 1) that reveals a structure larger and more complex 
than could be accounted for by two B chains alone (12, 26). 
Furthermore, B chain dimers have been shown to have a mo- 
bility similar to that of the 440-kD A chain on SDS-PAGE 
(34; and own unpublished observations), and no such spe- 
cies was seen in nonreduced RN22 cell laminin (Fig. 6 b). 
It is interesting to note that pulse-chase experiments with hu- 
man choriocarcinoma cells have shown that in order to be 
released from the cells, it is necessary for the A chain to be 
present  in  the  laminin  molecule (34),  whereas  A  chains 
alone can be released from both these and teratocarcinoma 
cells (10, 34; see also Fig. 6 a). Such observations have led 
to the suggestion that the A chain functions as a "secretory 
peptide" (34). If this should be the case, then RN22 laminin 
might contain a smaller A chain variant that comigrates with 
the B chains, and one that does not have those A chain epi- 
topes  recognized by blocking antibodies.  The speculative 
model presented in Fig.  1 is compatible with the Y-shaped 
(rather than  cross-shaped)  structure observed after rotary 
shadowing of purified RN22 cell laminin (12; Edgar, D., and 
M.  Paulsson, unpublished observations). 
The absence of a 440-kD A chain in RN22 Schwannoma 
laminin and elsewhere (12, 22, 24, 31) may be a consequence 
of  degradation.  However,  the  pulse-chase  experiments 
shown here do not provide evidence for the rapid degradation 
of A chain by RN22 cells. More definitive evidence for or 
against the possibility of specific A chain degradation awaits 
measurement of the relative levels of mRNAs for the individ- 
ual laminin chains. It should be noted however that low levels 
of A chain mRNA relative to that of the B chains have been 
reported recently in a variety of tissues (21). Thus, low levels 
of laminin 440-kD A chains, or the presence of A chain vari- 
ants that do not coss-react with the probes available, seems 
not to be restricted to RN22  Schwannoma cells.  Whether 
such variations in laminin result in differing biological prop- 
erties remains to be seen. 
Antibody Inhibition of  Neurite Outgrowth 
The analysis of the structure of RN22 cell laminin and its in- 
teraction with antibodies shows that the epitopes provided by 
the heparin-binding fragment are absent.  This observation 
provides a direct explanation why no antibody inhibition of 
RN22 laminin is seen: these epitopes are required if antisera 
against EHS laminin are to block neurite outgrowth. It has 
recently been reported that human placental laminin is un- 
able to bind heparin although it stimulates neurite outgrowth 
(17). Taken together, these results indicate that the heparin- 
binding fragment of EHS laminin does not constitute the ac- 
tual neurite-promoting site, and that the antibody inhibition 
observed is due to steric hindrance. One corollary of these 
observations is that the neurite-promoting site of native lami- 
nin molecules does not seem to be significantly antigenic, an- 
tibody inhibition relying either on epitopes provided by the 
440-kD A chain close to the site (as discussed for EHS lami- 
nin), or by more distant sites when the range of the blockade 
is increased by the use of secondary antibodies (17). Alterna- 
tively,  it has  been  shown that  a  blocking epitope can be 
created by the association of laminin with other molecules 
(7). 
The  accessibility  of epitopes  to  blocking  antibodies  is 
clearly a  prerequisite for inhibition of neurite outgrowth. 
This is well illustrated by differences in the susceptibilities 
to antibody inhibition of neurite outgrowth on laminin and 
its long arm fragment E8 (see model presented in Fig.  1). 
Antibodies raised against the 25-kD laminin B chain frag- 
ment from the end of the rodlike segment of the long arm 
show little inhibition of neurite outgrowth on laminin, as they 
fail to recognize this epitope efficiently within the native mol- 
ecule (33). Such antibodies are however able to recognize the 
long arm fragment E8 (see also reference 33), and so have 
the potential to block neurite outgrowth on this fragment. 
Thus, the rest of the intact laminin molecule is either hinder- 
ing access of these antibodies to their binding sites within the 
long arm, or alternatively the structure of the 25-kD frag- 
ment epitopes is constrained within the intact molecule, ren- 
dering them unrecognizable. 
As with all antibody inhibition studies, however, it cannot 
be concluded whether the anti-25 kD antibodies bind to the 
actual neurite-promoting site of fragment E8 (and therefore 
of laminin; see reference 16), or if their inhibitory activity, 
like that of antibodies to the heparin-binding fragment, is a 
consequence of steric hindrance. However, as the epitopes of 
the 25-kD fragment are also present on the (denatured) B 
chains of RN22 laminin, this fragment can now be regarded 
as a candidate to be either whole or part of the neurite-pro- 
moting site common to both EHS and RN22 laminins. The 
inability  of anti-25-kD  fragment  antibodies  to  recognize 
their epitopes when present in either EHS or RN22 laminins 
adds weight to this hypothesis, as it is consistent with the no- 
tion that the neurite-promoting site cannot be antigenically 
active in the native molecules (see above). This 25-kD frag- 
ment is well defined, its sequence and location within EHS 
laminin  being characterized (see references 26,  33).  This 
presents a possibility to construct oligopeptides that can be 
tested in competition with laminin for interactions with cells 
to establish directly if it constitutes the neurite-promoting 
site. 
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